![Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine](https://www.thelancet.com/cms/asset/2e79c946-a76f-459d-8e49-c3f1fef08276/gr1.jpg)
Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system - eClinicalMedicine
![4 reasons why Pfizer, BioNTech and Moderna must share COVID-19 mRNA vaccine technology NOW! | Médecins Sans Frontières Access Campaign 4 reasons why Pfizer, BioNTech and Moderna must share COVID-19 mRNA vaccine technology NOW! | Médecins Sans Frontières Access Campaign](https://msfaccess.org/sites/default/files/styles/msf_mobile/public/2021-09/covid19_nocoutnry_mrna_campaign_listile1_ac_2021_msb100125_1081px.png.webp?itok=mKUkdmk2)
4 reasons why Pfizer, BioNTech and Moderna must share COVID-19 mRNA vaccine technology NOW! | Médecins Sans Frontières Access Campaign
![mRNA Access: researchers of the Institut Pasteur can benefit from Moderna's mRNA platform for global health | Institut Pasteur mRNA Access: researchers of the Institut Pasteur can benefit from Moderna's mRNA platform for global health | Institut Pasteur](https://www.pasteur.fr/sites/default/files/styles/socialnetwork/public/innovation_en/adobestock_404350568.jpeg)
mRNA Access: researchers of the Institut Pasteur can benefit from Moderna's mRNA platform for global health | Institut Pasteur
![Moderna on X: "We just announced an agreement in principle with the Australian Government to build a state-of-the-art #mRNA vaccine manufacturing facility in Victoria, Australia including access to our mRNA development engine. Moderna on X: "We just announced an agreement in principle with the Australian Government to build a state-of-the-art #mRNA vaccine manufacturing facility in Victoria, Australia including access to our mRNA development engine.](https://pbs.twimg.com/media/FGhggyVXMAY1C7_.jpg:large)
Moderna on X: "We just announced an agreement in principle with the Australian Government to build a state-of-the-art #mRNA vaccine manufacturing facility in Victoria, Australia including access to our mRNA development engine.
![Gavi signs agreement with Moderna to secure doses on behalf of COVAX Facility | Gavi, the Vaccine Alliance Gavi signs agreement with Moderna to secure doses on behalf of COVAX Facility | Gavi, the Vaccine Alliance](https://www.gavi.org/sites/default/files/covid/pr/shutterstock_1891094320_h2.jpg)
Gavi signs agreement with Moderna to secure doses on behalf of COVAX Facility | Gavi, the Vaccine Alliance
![Moderna on X: "We're announcing our global public health strategy through four new initiatives aimed at advancing #mRNA #vaccines for the prevention of infectious diseases. https://t.co/gQfDu7XfLy https://t.co/k2WR6W7CIJ" / X Moderna on X: "We're announcing our global public health strategy through four new initiatives aimed at advancing #mRNA #vaccines for the prevention of infectious diseases. https://t.co/gQfDu7XfLy https://t.co/k2WR6W7CIJ" / X](https://pbs.twimg.com/media/FNSO23bWQAQXRj7.jpg)
Moderna on X: "We're announcing our global public health strategy through four new initiatives aimed at advancing #mRNA #vaccines for the prevention of infectious diseases. https://t.co/gQfDu7XfLy https://t.co/k2WR6W7CIJ" / X
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![4 reasons why Pfizer, BioNTech and Moderna must share COVID-19 mRNA vaccine technology NOW! | Médecins Sans Frontières Access Campaign 4 reasons why Pfizer, BioNTech and Moderna must share COVID-19 mRNA vaccine technology NOW! | Médecins Sans Frontières Access Campaign](https://msfaccess.org/sites/default/files/styles/msf_mobile/public/2021-09/covid19_nocoutnry_mrna_campaign_listile1_ac_2021_msb100132_1081px.png.webp?itok=FBXv5l54)